In another mechanism, METTL14 increases miR-93-5p expression and matures pri-miR-93-5p through m6A alteration to target and inhibit TXNIP, thereby inhibiting NSCLC cell apoptosis and promoting cancer development and metastasis (92). The gene discussed is METTL14; the disease is non-small cell lung carcinoma.